Context.—Thalassemia is a major health problem in Egypt. Red blood cell alloimmunization
is an important complication in transfusion-dependent patients. Objectives.—To determine …

Summary β‐thalassemia is considered a severe, progressive anemia, which needs regular
transfusions for life expectancy. One of the most important complications of regular blood …

Objective: Frequency of red cell ALLOIMMUNIZATION in patients with b-major-
THALASSEMIA in Mofid children's hospital. Tehran. Iran. Material & Methods: This is a cross …

SUMMARY Background In Pakistan routine blood group typing of thalassemia patients
identifies ABO and Rh (D) antigens only. Therefore, other antigen incompatibilities between …

Background: Transfusion is the mainstay treatment of patients with thalassemia major and
occasionally in thalassemia intermediate. Alloimmunization is an unwanted side effect of …

Background Beta thalassemia is considered a severe, progressive anemia, which needs
regular transfusions for life expectancy. One of the most important complications of regular …

Background Red blood cell (RBC) alloimmunization is a major challenge to repeated
transfusions in β-thalassemia-major patients. The aim of this study was to evaluate the …

Background: Thalassemia is one of the most common monogenic disorders characterized
by reduced production of globin chains. Although regular red blood cell (RBC) transfusion …

The development of hemolytic erythrocyte alloantibodies and autoantibodies complicates
transfusion therapy in thalassemia patients. These antibodies ultimately increase the need …

BACKGROUND β‐Thalassemia is considered the most common chronic hemolytic anemia
in Egypt. Alloimmunization can lead to serious clinical complications in transfusion …